US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Apimeds Pharmaceutical U.S, Inc.

7.05

-0.0800-1.12%

Post-market: 6.95-0.0971-1.38%17:54 EDT

Volume:22.35M

Turnover:191.46M

Market Cap:10.64M

PE:-0.18

High:9.84

Open:8.00

Low:6.86

Close:7.13

52wk High:59.70

52wk Low:1.51

Shares:1.51M

Float Shares:725.94K

Volume Ratio:1.43

T/O Rate:3079.34%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-38.5450

EPS(LYR):-0.1759

ROE:-144.99%

ROA:-69.29%

PB:1.30

PE(LYR):-40.09

Loading ...

Overview Company News Filings

Amex Halt Add Info Lst 4.940000

THOMSON REUTERS

Mindwave Innovations Signs Agreement with US-Based Blockassure to Build and Operate Assurechain, an End-to-End Insurance and Reinsurance Network

THOMSON REUTERS

Apimeds Pharmaceuticals Appoints Eric Sherb as New CFO

Apimeds Pharmaceuticals US - Appoints Eric Sherb as Chief Financial Officer Effective October 1, 2026 - SEC Filing

THOMSON REUTERS

MindWave expands blockchain services into sports media markets

Apimeds Unit MindWave Innovations to Deploy MindChain Blockchain for AQUAEChain Platform

Mindwave Innovations Expands U.S. Commercial Footprint with Second Agreement to Build and Operate Flashchain for New York-Based Flash Sports & Media

THOMSON REUTERS

Mindwave Innovations: Parties Have not Publicly Disclosed Aggregate Dollar Value of Consideration Under Agreement.

THOMSON REUTERS

Amex Halt Add Info Lst 7.920000

THOMSON REUTERS

Top Midday Gainers

MT Newswires Live

Why Is Apimeds Pharmaceuticals US Stock (APUS) Up Today?

Mindwave Innovations Signs Agreement to Build and Operate Aquaechain, a Platform for Insured Alci Credits

THOMSON REUTERS

Apimeds Pharmaceuticals US - Enters First Amendment to Settlement Agreement on Sept 10, 2026 - SEC Filing

THOMSON REUTERS

Apimeds Pharmaceuticals US - Board to Consist Solely of Four Members During Interim Period - SEC Filing

THOMSON REUTERS

Apimeds Pharmaceuticals US - Board to Expand to Seven Members After Interim Period - SEC Filing

THOMSON REUTERS

Apimeds Pharmaceuticals Adds Co-CEO Sungjoon Chae to Board

Apimeds Pharmaceuticals US Enters Assignment and Transfer Agreement with Freet on August 19

Apimeds Secures Key Apitox Rights via FreeT Agreement

Apimeds Pharmaceuticals US - Freet Assigns All Apitox-Related Rights to Apimeds Pharmaceuticals - SEC Filing

THOMSON REUTERS

Apimeds Pharmaceuticals US - Receives 100% Korean Clinic Rights, 25% U.S. Royalty, 25% Overseas Revenue Participation for Apitox - SEC Filing

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/APUS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"APUS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APUS\",,,,,undefined,":{"symbol":"APUS","market":"US","secType":"STK","nameCN":"Apimeds Pharmaceutical  U.S, Inc.","latestPrice":7.05,"timestamp":1791403200000,"preClose":7.13,"halted":0,"volume":22354246,"hourTrading":{"tag":"盘后","latestPrice":6.9529,"preClose":7.05,"latestTime":"17:54 EDT","volume":56045,"amount":391023.27483999997,"timestamp":1791410093793,"change":-0.0971,"changeRate":-0.013773,"amplitude":0.085106},"delay":0,"changeRate":-0.011220196353436195,"floatShares":725942,"shares":1509119,"eps":-38.545,"marketStatus":"Post-Mkt","change":-0.08,"latestTime":"10-07 17:55:05 EDT","open":8,"high":9.84,"low":6.86,"amount":191464720.55464202,"amplitude":0.417952,"askPrice":7.19,"askSize":50,"bidPrice":6.91,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-38.545,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791417600000},"marketStatusCode":4,"adr":0,"listingDate":1746763200000,"exchange":"AMEX","adjPreClose":7.13,"preHourTrading":{"tag":"盘前","latestPrice":7.97,"preClose":7.13,"latestTime":"09:29 EDT","volume":1209775,"amount":9748370.579325,"timestamp":1791379799999,"change":0.84,"changeRate":0.117812,"amplitude":0.23418},"postHourTrading":{"tag":"盘后","latestPrice":6.9529,"preClose":7.05,"latestTime":"17:54 EDT","volume":56045,"amount":391023.27483999997,"timestamp":1791410093793,"change":-0.0971,"changeRate":-0.013773,"amplitude":0.085106},"volumeRatio":1.431079},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APUS\",,,,,undefined,":{"symbol":"APUS","floatShares":725942,"roa":"-69.29%","roe":"-144.99%","lyrEps":-0.175862,"volumeRatio":1.431079,"shares":1509119,"dividePrice":0,"high":9.84,"amplitude":0.417952,"preClose":7.13,"low":6.86,"week52Low":1.51,"pbRate":"1.30","week52High":59.7,"institutionHeld":0,"latestPrice":7.05,"committee":0.333333,"eps":-38.545,"divideRate":0,"volume":22354246,"delay":0,"ttmEps":-38.545,"open":8,"prevYearClose":16.4,"prevWeekClose":3.22,"prevMonthClose":5,"prevQuarterClose":5,"fiveDayClose":5,"twentyDayClose":2.29,"sixtyDayClose":7.324},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/APUS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-24","symbol":"APUS","defaultRemindTime":1784899800000,"type":"split","dateTimestamp":1784865600000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"APUS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"APUS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/APUS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"APUS","date":"2025-12-01","current":-0.182903,"percent":0.642384,"low":-37.866629,"twenty":-14.293061,"median":-12.284712,"eighty":-6.374893,"high":-4.754876,"avg":-11.953693,"sd":7.073766,"marketCap":36470350},"quantilePoints":[{"date":"2025-02-21","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-02-28","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-03-05","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-05-09","current":-18.309826,"twenty":-34.716764,"median":-34.716764,"eighty":-33.299512,"marketCap":25450475},{"date":"2025-05-16","current":-14.148502,"twenty":-34.716764,"median":-34.008138,"eighty":-15.063993,"marketCap":19666276},{"date":"2025-05-23","current":-14.074662,"twenty":-34.716764,"median":-18.309826,"eighty":-14.306662,"marketCap":21054484},{"date":"2025-05-30","current":-13.387434,"twenty":-34.716764,"median":-15.063993,"eighty":-14.061031,"marketCap":20026450},{"date":"2025-06-06","current":-14.702962,"twenty":-34.716764,"median":-14.800251,"eighty":-13.996937,"marketCap":21994367},{"date":"2025-06-13","current":-14.314495,"twenty":-34.716764,"median":-14.564634,"eighty":-14.061031,"marketCap":21413253},{"date":"2025-06-20","current":-13.774354,"twenty":-33.866413,"median":-14.548195,"eighty":-14.0474,"marketCap":20605249},{"date":"2025-06-27","current":-13.296895,"twenty":-33.299512,"median":-14.356338,"eighty":-13.867215,"marketCap":19891011},{"date":"2025-07-03","current":-13.774354,"twenty":-27.303638,"median":-14.27266,"eighty":-13.727614,"marketCap":20605249},{"date":"2025-07-11","current":-14.006506,"twenty":-17.177946,"median":-14.161274,"eighty":-13.727614,"marketCap":20952529},{"date":"2025-07-18","current":-13.851738,"twenty":-15.354982,"median":-14.154888,"eighty":-13.727614,"marketCap":20721009},{"date":"2025-07-25","current":-16.173259,"twenty":-16.219689,"median":-14.161274,"eighty":-13.727614,"marketCap":24193804},{"date":"2025-08-01","current":-13.464818,"twenty":-16.219689,"median":-14.199966,"eighty":-13.727614,"marketCap":20142210},{"date":"2025-08-08","current":-12.14929,"twenty":-16.049445,"median":-14.148502,"eighty":-13.573156,"marketCap":18174293},{"date":"2025-08-15","current":-12.265366,"twenty":-15.710284,"median":-14.056061,"eighty":-13.418388,"marketCap":18347933},{"date":"2025-08-22","current":-7.697345,"twenty":-15.447843,"median":-14.006506,"eighty":-13.015991,"marketCap":28547481},{"date":"2025-08-29","current":-6.307075,"twenty":-15.306558,"median":-13.929122,"eighty":-12.721932,"marketCap":23391328},{"date":"2025-09-05","current":-6.307075,"twenty":-15.146611,"median":-13.929122,"eighty":-12.474303,"marketCap":23391328},{"date":"2025-09-12","current":-6.578348,"twenty":-15.038217,"median":-13.851738,"eighty":-12.234412,"marketCap":24397407},{"date":"2025-09-19","current":-6.205348,"twenty":-14.9276,"median":-13.774354,"eighty":-7.507455,"marketCap":23014048},{"date":"2025-09-26","current":-6.049367,"twenty":-14.889578,"median":-13.773581,"eighty":-6.849619,"marketCap":22435553},{"date":"2025-10-03","current":-5.832349,"twenty":-14.826776,"median":-13.69697,"eighty":-6.578348,"marketCap":21630690},{"date":"2025-10-10","current":-6.307075,"twenty":-14.675296,"median":-13.542202,"eighty":-6.472551,"marketCap":23391328},{"date":"2025-10-17","current":-6.239257,"twenty":-14.561346,"median":-13.50351,"eighty":-6.415584,"marketCap":23139808},{"date":"2025-10-24","current":-5.879822,"twenty":-14.548195,"median":-13.387434,"eighty":-6.358617,"marketCap":21806754},{"date":"2025-10-31","current":-6.917438,"twenty":-14.538909,"median":-13.039206,"eighty":-6.374893,"marketCap":25655005},{"date":"2025-11-07","current":-8.524725,"twenty":-14.481047,"median":-12.845746,"eighty":-6.381675,"marketCap":31616021},{"date":"2025-11-14","current":-9.460613,"twenty":-14.381444,"median":-12.652286,"eighty":-6.415584,"marketCap":35086992},{"date":"2025-11-21","current":-5.852155,"twenty":-14.312928,"median":-12.458826,"eighty":-6.415584,"marketCap":30182359},{"date":"2025-11-28","current":-7.071353,"twenty":-14.306662,"median":-12.304058,"eighty":-6.374893,"marketCap":36470350},{"date":"2025-12-01","current":-7.071353,"twenty":-14.293061,"median":-12.284712,"eighty":-6.374893,"marketCap":36470350}],"updateTime":1791410105962},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"APUS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673083106","title":"Amex Halt Add Info Lst 4.940000","url":"https://stock-news.laohu8.com/highlight/detail?id=2673083106","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673083106?lang=en_us&edition=fundamental","pubTime":"2026-10-05 23:00","pubTimestamp":1791212427,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nAQN2MMW81:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673964702","title":"Mindwave Innovations Signs Agreement with US-Based Blockassure to Build and Operate Assurechain, an End-to-End Insurance and Reinsurance Network","url":"https://stock-news.laohu8.com/highlight/detail?id=2673964702","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673964702?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:00","pubTimestamp":1791201601,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA2MHWJG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","APUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672887768","title":"Apimeds Pharmaceuticals Appoints Eric Sherb as New CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2672887768","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672887768?lang=en_us&edition=fundamental","pubTime":"2026-10-01 21:50","pubTimestamp":1790862655,"startTime":"0","endTime":"0","summary":"Apimeds Pharmaceuticals US, Inc. ( ($APUS) ) just unveiled an announcement. Apimeds Pharmaceuticals US, Inc. announced that on September 29, 2026, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/apimeds-pharmaceuticals-appoints-eric-sherb-as-new-cfo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/apimeds-pharmaceuticals-appoints-eric-sherb-as-new-cfo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","APUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672975703","title":"Apimeds Pharmaceuticals US - Appoints Eric Sherb as Chief Financial Officer Effective October 1, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2672975703","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672975703?lang=en_us&edition=fundamental","pubTime":"2026-10-01 21:16","pubTimestamp":1790860573,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45N13W:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671291247","title":"MindWave expands blockchain services into sports media markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2671291247","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671291247?lang=en_us&edition=fundamental","pubTime":"2026-09-30 04:52","pubTimestamp":1790715149,"startTime":"0","endTime":"0","summary":"Apimeds Pharmaceuticals US, Inc. ( ($APUS) ) just unveiled an announcement. On September 24, 2026, MindWave Innovations Inc., a subsidiary of Apime...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mindwave-expands-blockchain-services-into-sports-media-markets?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mindwave-expands-blockchain-services-into-sports-media-markets?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HECO","APUS","BK4139","BKCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671242723","title":"Apimeds Unit MindWave Innovations to Deploy MindChain Blockchain for AQUAEChain Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2671242723","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671242723?lang=en_us&edition=fundamental","pubTime":"2026-09-30 04:16","pubTimestamp":1790712993,"startTime":"0","endTime":"0","summary":"Apimeds unit MindWave Innovations to deploy MindChain blockchain for AQUAEChain platformMindWave Innovations, a unit of Apimeds Pharmaceuticals US, signed a 12-month technology services deal with AQUA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL4pfpGw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671952214","title":"Mindwave Innovations Expands U.S. Commercial Footprint with Second Agreement to Build and Operate Flashchain for New York-Based Flash Sports & Media","url":"https://stock-news.laohu8.com/highlight/detail?id=2671952214","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671952214?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:33","pubTimestamp":1790685180,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L0OH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671214954","title":"Mindwave Innovations: Parties Have not Publicly Disclosed Aggregate Dollar Value of Consideration Under Agreement.","url":"https://stock-news.laohu8.com/highlight/detail?id=2671214954","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671214954?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:33","pubTimestamp":1790685180,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L0OH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","APUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670428648","title":"Amex Halt Add Info Lst 7.920000","url":"https://stock-news.laohu8.com/highlight/detail?id=2670428648","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670428648?lang=en_us&edition=fundamental","pubTime":"2026-09-25 21:39","pubTimestamp":1790343587,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nAQN2MKV1I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670497682","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2670497682","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670497682?lang=en_us&edition=fundamental","pubTime":"2026-09-25 01:46","pubTimestamp":1790272002,"startTime":"0","endTime":"0","summary":"Everpure (P) reaffirmed fiscal 2027 adjusted operating income guidance of $940 million to $960 million on revenue of $5.03 billion to $5.07 billion late Wednesday. FactSet-polled analysts expect $959.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["APUS","BK4009","BK4588","PUL","TJGC","BK4170","BK4585","P","LU0154245673.USD","LU0154245756.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670492938","title":"Why Is Apimeds Pharmaceuticals US Stock (APUS) Up Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2670492938","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670492938?lang=en_us&edition=fundamental","pubTime":"2026-09-25 00:39","pubTimestamp":1790267961,"startTime":"0","endTime":"0","summary":"Apimeds Pharmaceuticals US stock rallied after the company reached a deal with AQUAE to manage AQUAEChain.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-is-apimeds-pharmaceuticals-us-stock-apus-up-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-is-apimeds-pharmaceuticals-us-stock-apus-up-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","APUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669749832","title":"Mindwave Innovations Signs Agreement to Build and Operate Aquaechain, a Platform for Insured Alci Credits","url":"https://stock-news.laohu8.com/highlight/detail?id=2669749832","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669749832?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:30","pubTimestamp":1790253028,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nFWN45G0DM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","APUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666522022","title":"Apimeds Pharmaceuticals US - Enters First Amendment to Settlement Agreement on Sept 10, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2666522022","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666522022?lang=en_us&edition=fundamental","pubTime":"2026-09-11 21:11","pubTimestamp":1789132313,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nFWN45306Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666220035","title":"Apimeds Pharmaceuticals US - Board to Consist Solely of Four Members During Interim Period - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2666220035","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666220035?lang=en_us&edition=fundamental","pubTime":"2026-09-11 21:11","pubTimestamp":1789132313,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nFWN45306Z:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666006522","title":"Apimeds Pharmaceuticals US - Board to Expand to Seven Members After Interim Period - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2666006522","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666006522?lang=en_us&edition=fundamental","pubTime":"2026-09-11 21:11","pubTimestamp":1789132313,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nFWN45306Z:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666152207","title":"Apimeds Pharmaceuticals Adds Co-CEO Sungjoon Chae to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2666152207","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666152207?lang=en_us&edition=fundamental","pubTime":"2026-09-11 21:11","pubTimestamp":1789132287,"startTime":"0","endTime":"0","summary":"Apimeds Pharmaceuticals adds Co-CEO Sungjoon Chae to boardApimeds Pharmaceuticals US amended a settlement to reset board control ahead of a preferred stock conversion.Interim board set at four directo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL1Kss6C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661226290","title":"Apimeds Pharmaceuticals US Enters Assignment and Transfer Agreement with Freet on August 19","url":"https://stock-news.laohu8.com/highlight/detail?id=2661226290","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661226290?lang=en_us&edition=fundamental","pubTime":"2026-08-22 05:31","pubTimestamp":1787347904,"startTime":"0","endTime":"0","summary":"BRIEF-Apimeds Pharmaceuticals US Enters Assignment And Transfer Agreement With Freet On August 19Aug 21 -Apimeds Pharmaceuticals US IncAPUS.A:APIMEDS PHARMACEUTICALS US - ENTERS ASSIGNMENT AND TRANSFER AGREEMENT WITH FREET ON AUG 19, 2026 - SEC FILINGAPIMEDS PHARMACEUTICALS US - FREET ASSIGNS ALL APITOX-RELATED RIGHTS TO APIMEDS PHARMACEUTICALS - SEC FILINGAPIMEDS PHARMACEUTICALS US - RECEIVES 100% KOREAN CLINIC RIGHTS, 25% U.S. ROYALTY, 25% OVERSEAS REVENUE PARTICIPATION FOR APITOX - SEC FILINGAPIMEDS PHARMACEUTICALS US - ASSIGNED RIGHTS ARE FREE AND CLEAR OF PRIOR CLAIMS OR ENCUMBRANCES - SEC FILINGSource text: [ID:n0001213900-26-092680]Further company coverage:APUS.A","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nFWN44I0JA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661907092","title":"Apimeds Secures Key Apitox Rights via FreeT Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2661907092","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661907092?lang=en_us&edition=fundamental","pubTime":"2026-08-22 05:27","pubTimestamp":1787347671,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Apimeds Pharmaceuticals US, Inc. ( ($APUS) ). On August 19, 2026, Apimeds Pharmaceuticals US, Inc. entered into...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/apimeds-secures-key-apitox-rights-via-freet-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/apimeds-secures-key-apitox-rights-via-freet-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661909292","title":"Apimeds Pharmaceuticals US - Freet Assigns All Apitox-Related Rights to Apimeds Pharmaceuticals - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2661909292","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661909292?lang=en_us&edition=fundamental","pubTime":"2026-08-22 05:13","pubTimestamp":1787346814,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nFWN44I0JA:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","APUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661290926","title":"Apimeds Pharmaceuticals US - Receives 100% Korean Clinic Rights, 25% U.S. Royalty, 25% Overseas Revenue Participation for Apitox - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2661290926","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661290926?lang=en_us&edition=fundamental","pubTime":"2026-08-22 05:13","pubTimestamp":1787346814,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nFWN44I0JA:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":51,"code":"91000000","status":"200"}]}}